Nalaganje...
A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact.
In a Perspective accompanying Hill and colleagues, Elliot Marseille and James Kahn compare the history of pricing and availability of ART for HIV with that of the new HCV drugs and discuss strategies for providing treatment in LMIC even in the face of high costs.
Shranjeno v:
Main Authors: | , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Public Library of Science (PLoS)
2016-05-01
|
Serija: | PLoS Medicine |
Online dostop: | http://europepmc.org/articles/PMC4886960?pdf=render |
Oznake: |
Označite
Brez oznak, prvi označite!
|